Form 8-K - Current report:
SEC Accession No. 0001641172-25-014899
Filing Date
2025-06-12
Accepted
2025-06-12 16:50:48
Documents
21
Period of Report
2025-05-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 45303
2 EX-3.1_I ex3-1_i.htm EX-3.1_I 3738
3 EX-99.1 ex99-1.htm EX-99.1 9334
4 EX-99.2 ex99-2.htm EX-99.2 8428
5 GRAPHIC ex3-1i_001.jpg GRAPHIC 135329
6 GRAPHIC ex3-1i_002.jpg GRAPHIC 520227
7 GRAPHIC ex3-1i_003.jpg GRAPHIC 638148
8 GRAPHIC ex3-1i_004.jpg GRAPHIC 697470
9 GRAPHIC ex99-1_001.jpg GRAPHIC 4489
10 GRAPHIC ex99-2_001.jpg GRAPHIC 4586
  Complete submission text file 0001641172-25-014899.txt   2996243

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE aim-20250529.xsd EX-101.SCH 3014
12 XBRL LABEL FILE aim-20250529_lab.xml EX-101.LAB 34239
13 XBRL PRESENTATION FILE aim-20250529_pre.xml EX-101.PRE 22359
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3683
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 251043587
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)